BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27423380)

  • 1. Complete molar pregnancy in adolescents from North and South America: Clinical presentation and risk of gestational trophoblastic neoplasia.
    Soares RR; Maestá I; Colón J; Braga A; Salazar A; Charry RC; Sun SY; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 2016 Sep; 142(3):496-500. PubMed ID: 27423380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
    Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
    Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review.
    Lin LH; Maestá I; Braga A; Sun SY; Fushida K; Francisco RPV; Elias KM; Horowitz N; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 2017 Apr; 145(1):88-95. PubMed ID: 28132722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
    Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
    Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
    Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
    Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
    Cho HW; Ouh YT; Min KJ; Lee NW; Lee S; Song JY; Hong JH; Lee JK
    Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center.
    Vargas R; Barroilhet LM; Esselen K; Diver E; Bernstein M; Goldstein DP; Berkowitz RS
    J Reprod Med; 2014; 59(5-6):188-94. PubMed ID: 24937955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America.
    Maestá I; de Freitas Segalla Moreira M; Rezende-Filho J; Bianconi MI; Jankilevich G; Otero S; Correa Ramirez LA; Sun SY; Elias K; Horowitz N; Braga A; Berkowitz R
    Int J Gynecol Cancer; 2020 Sep; 30(9):1366-1371. PubMed ID: 32376739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molar pregnancy in adolescents.
    Braga A; Growdon WB; Bernstein M; Maestá I; Rudge MV; Goldstein DP; Berkowitz RS
    J Reprod Med; 2012; 57(5-6):225-30. PubMed ID: 22696817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
    Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
    Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gestational trophoblastic neoplasia in adolescents.
    Rauh-Hain JA; Growdon WB; Braga A; Goldstein DP; Berkowitz RS
    J Reprod Med; 2012; 57(5-6):237-42. PubMed ID: 22696819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
    Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
    Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
    Sato A; Usui H; Shozu M
    Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of gestational trophoblastic diseases.
    Berkowitz RS; Goldstein DP
    Gynecol Oncol; 2009 Mar; 112(3):654-62. PubMed ID: 18851873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.